# EDGAR Filing Document

**Accession Number:** 0000946644
**File Stem:** 0001641172-25-016920
**Filing Date:** 2025-6
**Character Count:** 2258
**Document Hash:** 0704c8ca1d10604dc7e027ef4be5f2d3
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001641172-25-016920.hdr.sgml**: 20250801

**ACCESSION NUMBER**: 0001641172-25-016920

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250627

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AIM ImmunoTech Inc.
- **CENTRAL INDEX KEY:** 0000946644
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 520845822
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 2117 SW HIGHWAY 484
- **CITY:** OCALA
- **STATE:** FL
- **ZIP:** 32801
- **BUSINESS PHONE:** 352-448-7797

**MAIL ADDRESS:**
- **STREET 1:** 2117 SW HIGHWAY 484
- **CITY:** OCALA
- **STATE:** FL
- **ZIP:** 32801

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEMISPHERX BIOPHARMA INC
- **DATE OF NAME CHANGE:** 19950614

---

| | |
|:---|:---|
| SILVERMAN SHIN & BYRNE PLLC<br> Wall Street Plaza<br> 22nd Floor<br> 88 Pine Street<br> NEW YORK, NY 10005<br> 212.779.8600<br> Facsimile: 212.779.8858<br>| **New Jersey**<br>19 Engle Street<br> Tenafly, NJ 07670<br> (201) 567-4969<br>|

---

June 27, 2025

<u>VIA EDGAR</u>

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Re: AIM ImmunoTech Inc. (the "Company") <br> <u>Registration Statement on Form S-3, SEC file no.: 333-286319</u>

Dear Sir or Madam:

On behalf of the Company we file herewith Amendment No. 1 to the above referenced registration statement on Form S-3, a universal shelf registration.

Previously, the Company received a no-review letter. Assuming that the Commission still will not be reviewing the registration statement, the Company plans on seeking effectiveness as soon as possible.

Please direct any questions or comments to the undersigned, Richard Feiner, Esq., 646 822-1170 (<u>rfeiner@silverfirm.com</u>).

The contact person at the Company is Peter W. Rodin III, COO. His e-mail address is <u>Peter.rodino@aimimmuno.com</u> and his phone number is (239) 444-1743.

---

| |
|:---|
| Very truly yours, |
| /s/ Richard Feiner |
| Richard Feiner |

---

cc: AIM ImmunoTech Inc.